The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat.
about
Antitussive activity of sigma-1 receptor agonists in the guinea-pigDextromethorphan and quinidine combination for heroin detoxification.Dextromethorphan differentially affects opioid antinociception in rats.Improving opioid effectiveness: from ideas to evidence.Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidineThe therapeutic effect of adding dextromethorphan to clonidine for reducing symptoms of opioid withdrawal: a randomized clinical trial.
P2860
The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@en
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@nl
type
label
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@en
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@nl
prefLabel
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@en
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@nl
P2093
P1476
The clinically available NMDA ...... ithdrawal in the neonatal rat.
@en
P2093
Charles E Inturrisi
Hongbo Zhu
Kathy L Jones
Shirzad Jenab
P304
P356
10.1016/S0165-3806(03)00059-2
P577
2003-05-01T00:00:00Z